Takeda Files First BPCIA Suit Over Entyvio Biosimilar

Takeda Pharmaceuticals has filed a patent infringement lawsuit in New Jersey against Polpharma, marking the first BPCIA litigation over a proposed biosimilar for the blockbuster drug Entyvio.